Eduardo Bravo

4PUBLICATIONS
43CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Computational physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 13, 2026
Targeting Bruton's Tyrosine Kinase in CLL: Selectivity, Resistance Mechanisms, and Emerging Therapeutic Strategies.

|Jul 22, 2026
Molecular and Structural Basis of Pan-Resistance to BTK Degraders and Inhibitors.

|Sep 27, 2025
Resistance Mutations in CLL: Genetic Mechanisms Shaping the Future of Targeted Therapy.

Samantha Sekeres, Erica N Lamkin, Eduardo Bravo

|Jul 29, 2025
Modulating the Binding Kinetics of Bruton's Tyrosine Kinase Inhibitors through Transition-State Effects.

Eduardo Bravo, Yong Li, David Yin-Wei Lin

Pageof 1

Frequent Collaborators

3 joint publications

Erica N Lamkin

3 joint publications

Justin Taylor

2 joint publications

Allison Cool

1 joint publications

Bharath Srinivasan